![Sona Saira Ramasastry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sona Saira Ramasastry
Directeur/Membre du Conseil chez GLENMARK PHARMACEUTICALS LIMITED
Fortune : 820 073 $ au 31/05/2024
Postes actifs de Sona Saira Ramasastry
Sociétés | Poste | Début | Fin |
---|---|---|---|
GLENMARK PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 01/04/2019 | - |
Independent Dir/Board Member | 01/04/2019 | - | |
VIR BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 01/09/2019 | - |
Independent Dir/Board Member | 01/09/2019 | - | |
DAY ONE BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/03/2021 | - |
Independent Dir/Board Member | 01/03/2021 | - | |
MIRUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/06/2022 | - |
Independent Dir/Board Member | 02/06/2022 | - | |
DOT Therapeutics-2, Inc.
![]() DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 12/04/2021 | - |
European Prevention of Alzheimer's Dementia Consortium | Corporate Officer/Principal | - | - |
Elevian, Inc.
![]() Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Directeur/Membre du Conseil | - | - |
Pain Therapeutics, Inc.
![]() Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Directeur/Membre du Conseil | - | - |
Aspen Global Leadership Network | Corporate Officer/Principal | - | - |
░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - |
Historique de carrière de Sona Saira Ramasastry
Anciens postes connus de Sona Saira Ramasastry
Sociétés | Poste | Début | Fin |
---|---|---|---|
░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░░ ░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Sona Saira Ramasastry
Stanford University | Graduate Degree |
University of Cambridge | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 17 |
Royaume-Uni | 2 |
Inde | 2 |
Opérationnelle
Director/Board Member | 13 |
Independent Dir/Board Member | 9 |
Corporate Officer/Principal | 3 |
Sectorielle
Health Technology | 13 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 7 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
CASSAVA SCIENCES, INC. | Health Technology |
9 METERS BIOPHARMA, INC. | Health Technology |
GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 10 |
---|---|
Life Sciences Advisory LLC | |
American Liver Foundation
![]() American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Commercial Services |
Repros Therapeutics, Inc.
![]() Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Wasserstein Perella & Co., Inc. | |
Aspen Global Leadership Network | |
Pain Therapeutics, Inc.
![]() Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Health Technology |
Elevian, Inc.
![]() Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
Akouos, Inc.
![]() Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
European Prevention of Alzheimer's Dementia Consortium | |
DOT Therapeutics-2, Inc.
![]() DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Sona Saira Ramasastry
- Expérience